Community
Advertising Opportunities
Biotechnology Europe Programs
Biotechnology Europe Community
Feedback
Contact
Biotechnology Europe Advantages
Advertising Opportunities on Biotechnology Europe
Sponsorship Opportunities on Biotechnology Europe
Post a Job on Biotechnology Europe
Post a Company Profile on Biotechnology Europe
Post a News on Biotechnology Europe
Post an Event on Biotechnology Europe
Post a Product on Biotechnology Europe
Post a Publication on Biotechnology Europe
Post a Technology on Biotechnology Europe
Post a Resume on Biotechnology Europe
Terms of Business
Imprint
Privacy Policy
FAQ
Subscribe Newsletter
BIOTECHNOLOGY EUROPE-NORTH AMERICA
post your news I subscribe newsletter I contact us
27.12.2007 Cell Therapeutics, Inc. (CTI) Completes Acquisition of Lymphoma Drug Zevalin(R) From Biogen Idec for Sales and Marketing in the United States
20.12.2007 Cell Therapeutics, Inc. Announces $7 Million Offering
20.12.2007 Genentech Announces January 14 Webcast Discussion of Financial and Other Business Results
18.12.2007 Cell Therapeutics, Inc. (CTI) to Submit Marketing Authorization Application for XYOTAX(TM) for First-line Non-small Cell Lung Cancer Ahead of Schedule
11.12.2007 Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting
10.12.2007 Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103/Vidaza(R) Study in Myelodysplastic Syndromes and Acute Myelogenous Leukemia at The 49th American Society of Hematology (ASH) Meeting
07.12.2007 Pivotal Phase 3 Romiplostim Study in Splenectomized Patients Meets Primary Endpoints
04.12.2007 Cell Therapeutics, Inc. Closes $6.5 Million Offering
